MXMiaomiao Xu

Miaomiao Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miaomiao Xu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Jing Yuan

    Department of Pathology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China

    1 shared publication
  • Xiao Zhang

    CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, 100190, China

    1 shared publication
  • Xinlian Wang

    CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, 100190, China

    1 shared publication
  • Ying Liu

    Department of Physics and Hebei Advanced Thin Film Laboratory, Hebei Normal University, Shijiazhuang, 050024, China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Monocyte/macrophage-mediated trained immunity in disease prevention and immunotherapy

    by Xiao Zhang, Xinlian Wang, Miaomiao Xu, Jing Yuan, Ying Liu

    Trained immunity refers to a functional reprogramming of the innate immune system that enhances its ability to respond to secondary stimuli. Monocytes and macrophages are central effectors of innate immunity with broad therapeutic relevance. Their capacity to acquire trained immunity enhances host defense and shapes immune homeostasis through epigenetic, metabolic, and functional changes. Unlike previous reviews that primarily focus on molecular mechanisms or vaccine-induced training, this review emphasizes the distinct roles of monocyte/macrophage-mediated trained immunity, originating from both central and peripheral sources. We further discuss how nanomaterials can be harnessed to precisely modulate this process, offering new opportunities for infection control, tumor immunotherapy, and the regulation of chronic inflammatory diseases. This dual-perspective framework provides a foundation for translating trained immunity into targeted clinical interventions.